Status:
UNKNOWN
Checking Wether the m-ALA Cream Could Mark Correctly the Borders of BCC's Tumors
Lead Sponsor:
Assuta Hospital Systems
Conditions:
Basal Cell Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Correlation between Mohs surgery and microscopic fluorescence photometry in determination of histological borders in Basal Cell Carcinoma .
Detailed Description
Background: Basal Cell Carcinoma (BCC) is the most common form of nonmelanoma skin cancer worldwide. BCCs are slow-growing, locally invasive tumors that rarely metastasize but can cause extensive morb...
Eligibility Criteria
Inclusion
- A- bove 18 years
Exclusion
- Childern
- Pregnant women
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
End Date :
April 1 2013
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00449358
Start Date
February 1 2006
End Date
April 1 2013
Last Update
April 16 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuta hospital
Tel Aviv, Israel